⚡ Technology🌐 Global
FDA Advisors Unanimously Back Moderna's mRNA Vaccine After Months of Political Chaos
Ars Technica·Sunday, 21 June 2026
FDA advisory panel members voted unanimously to recommend approval of Moderna's mRNA vaccine, following months of turmoil that included a Trump administration official refusing to review it back in February. The unanimous vote is a significant step toward formal approval.
Why It Matters
mRNA vaccine technology has global health implications, and a US approval after political interference signals whether science or politics drives drug regulation — a question relevant everywhere.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.